Nunzia Pharmaceutical Corporation Stock Other OTC
Equities
NUNZ
US67097W1027
Pharmaceuticals
Sales 2020 | - | Sales 2021 | - | Capitalization | 170M 231M |
---|---|---|---|---|---|
Net income 2020 | -9M -12.26M | Net income 2021 | -78M -106M | EV / Sales 2020 | - |
Net cash position 2020 * | - 0 | Net Debt 2021 | 97.31K 133K | EV / Sales 2021 | - |
P/E ratio 2020 |
-94.8
x | P/E ratio 2021 |
-2.54
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 18.04% |
Managers | Title | Age | Since |
---|---|---|---|
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
President | 68 | 08-12-31 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 19-12-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 68 | 08-12-31 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 19-12-04 |
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+31.74% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |